Cited by 212Hepatitis B Virus StudiesHepatitis C virus researchHealth Promotion and Cardiovascular Prevention

The DOI matches its Crossref record; 44 of the 49 references it cites were found in a registry or an index.

Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement

Open access

US Preventive Services Task Force, Krist, Alex H., Davidson, Karina W., Mangione, Carol M., Barry, Michael J., Cabana, Michael, Caughey, Aaron B., Donahue, Katrina, Doubeni, Chyke A., Epling, John W., Kubik, Martha, Ogedegbe, Gbenga, Owens, Douglas K., Pbert, Lori, Silverstein, Michael, Simon, Melissa A., Tseng, Chien-Wen, Wong, John B.·2020·JAMA

DOI 10.1001/jama.2020.22980

Open this paper in CoChat — free account Open PDF

Abstract

Importance: An estimated 862 000 persons in the US are living with chronic infection with hepatitis B virus (HBV). Persons born in regions with a prevalence of HBV infection of 2% or greater, such as countries in Africa and Asia, the Pacific Islands, and parts of South America, often become infected at birth and account for up to 95% of newly reported chronic infections in the US. Other high-prevalence populations include persons who inject drugs; men who have sex with men; persons with HIV infection; and sex partners, needle-sharing contacts, and household contacts of persons with chronic HBV infection. Up to 60% of HBV-infected persons are unaware of their infection, and many remain asymptomatic until onset of cirrhosis or end-stage liver disease. Objective: To update its 2014 recommendation, the USPSTF commissioned a review of new randomized clinical trials and cohort studies published from 2014 to August 2019 that evaluated the benefits and harms of screening and antiviral therapy for preventing intermediate outcomes or health outcomes and the association between improvements in intermediate outcomes and health outcomes. New key questions focused on the yield of alternative HBV screening strategies and the accuracy of tools to identify persons at increased risk. Population: This recommendation statement applies to asymptomatic, nonpregnant adolescents and adults at increased risk for HBV infection, including those who were vaccinated before being screened for HBV infection. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for HBV infection in adolescents and adults at increased risk for infection has moderate net benefit. Recommendation: The USPSTF recommends screening for HBV infection in adolescents and adults at increased risk for infection. (B recommendation).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2020.22980

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Centers for Disease Control and Prevention
Branum, A. (2007) · Sage eBooks · doi:10.4135/9781412952644.n74 · Cited by 6,434
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
Schweitzer, A., Horn, J., Mikolajczyk, R., Krause, G., & Ott, J. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61412-x · Cited by 2,747
Sexually transmitted diseases treatment guidelines (2015)
Workowski, K., & BOLAN, G. A. (2015) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2015.24.51-56 · Cited by 2,684
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Jarlais, D. C. D., Horyniak, D., & Degenhardt, L. J. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61097-0 · Cited by 1,266
Sexually Transmitted Diseases Treatment Guidelines 2002
(2002) · PsycEXTRA Dataset · doi:10.1037/e548482006-001 · Cited by 1,238
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Ghany, M. G., Morgan, T. R. M., & Panel, A. H. C. G. (2019) · Hepatology · doi:10.1002/hep.31060 · Cited by 991
The natural history of chronic hepatitis B virus infection #
McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.22898 · Cited by 879
Recommendations for identification and public health management of persons with chronic hepatitis B virus infection #
Weinbaum, C. M., Mast, E. E., & Ward, J. W. (2009) · Hepatology · doi:10.1002/hep.22882 · Cited by 818
Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815

Show all 49 references

Sorted by citations

Cancer Statistics, 2021
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore
Wong, J., Goh, Q. Y., Tan, Z., Lie, S. A., Tay, Y. C., Ng, S. Y., & Soh, C. R. (2020) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-020-01620-9 · Cited by 731
CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
Schillie, S. F., Wester, C., Osborne, M. C., Wesolowski, L. G., & Ryerson, A. B. (2020) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6902a1 · Cited by 565
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023
Conners, E. E., Panagiotakopoulos, L., Hofmeister, M. G., Spradling, P. R., Hagan, L. M., Harris, A. M., Rogers-Brown, J. S., Wester, C. W., Nelson, N. P., Contributors, et al. (2023) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr7201a1 · Cited by 310
Screening for Chlamydia and Gonorrhea
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M. D., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., et al. (2021) · JAMA · doi:10.1001/jama.2021.14081 · Cited by 177
Vital Signs:Newly Reported Acute and Chronic Hepatitis C Cases ― United States, 2009–2018
Ryerson, A. B., Schillie, S. F., Barker, L. K., Kupronis, B. A., & Wester, C. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6914a2 · Cited by 165
Viral hepatitis and pregnancy
Terrault, N. A., Levy, M. T., Cheung, K. W., & Jourdain, G. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00361-w · Cited by 155
An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign‐Born Persons Living in the United States
Wong, R. J., Brosgart, C. L., Welch, S., Block, T., Chen, M. I.-C., Cohen, C. A., Kim, W. R., Kowdley, K. V., Lok, A. S.-F., Tsai, N. C. S., et al. (2021) · Hepatology · doi:10.1002/hep.31782 · Cited by 146
Progress towards hepatitis C virus elimination in high‐income countries: An updated analysis
Gamkrelidze, I., Pawlotsky, J., Lazarus, J. V., Feld, J. J., Zeuzem, S., Bao, Y., dos Santos, A. G. P., González, Y. S., & Razavi, H. A. (2021) · Liver International · doi:10.1111/liv.14779 · Cited by 133
Viral hepatitis: Past, present, and future
Odenwald, M. A., & Paul, S. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i14.1405 · Cited by 138
Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019
Liu, Y., Zheng, J., Hao, J., Wang, R. R., Liu, X., Gu, P., Yu, H., Yu, Y., Wu, C.-X., Ou, B., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.4551 · Cited by 125
Prevalence and Modes of Transmission of Hepatitis C Virus Infection: A Historical Worldwide Review
Stroffolini, T., & Stroffolini, G. (2024) · Viruses · doi:10.3390/v16071115 · Cited by 113
Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic
Kaufman, H. W., Bull–Otterson, L., Meyer, W. A., Huang, X., Doshani, M., Thompson, W., Osinubi, A., Khan, M. A., Harris, A. M., Gupta, N., et al. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.03.011 · Cited by 88
CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children — United States, 2023
Panagiotakopoulos, L., Sandul, A. L., DHSc, Conners, E. E., Foster, M. A., Nelson, N. P., Wester, C., Collaborators, Collaborators, Barnett, E. D., et al. (2023) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr7204a1 · Cited by 79
Treatment of opioid use disorder in primary care
Buresh, M., Stern, R. S., & Rastegar, D. A. (2021) · BMJ · doi:10.1136/bmj.n784 · Cited by 69
Preexposure Prophylaxis to Prevent Acquisition of HIV
US Preventive Services Task Force, Barry, M. J., Nicholson, W. K., Silverstein, M., Chelmow, D. P., Coker, T. R., Davis, E. M., Donahue, K. E., Jaén, C. R., Kubik, M., et al. (2023) · JAMA · doi:10.1001/jama.2023.14461 · Cited by 70
Screening for Syphilis Infection in Nonpregnant Adolescents and Adults
US Preventive Services Task Force, Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M. D., Chelmow, D. P., Coker, T. R., Davis, E. M., Donahue, K. E., Jaén, C. R., et al. (2022) · JAMA · doi:10.1001/jama.2022.15322 · Cited by 66
Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019
Wang, S., Toy, M., Pham, T. T. H., & So, S. K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239393 · Cited by 65
Contemporary Insights into Hepatitis C Virus: A Comprehensive Review
Sallam, M., & Khalil, R. (2024) · Microorganisms · doi:10.3390/microorganisms12061035 · Cited by 80
Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018
Sharma, R. (2020) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaa130 · Cited by 57
Digestive Health in Sexual and Gender Minority Populations
Vélez, C. D., Casimiro, I., Pitts, R. A., Streed, C. G., & Paul, S. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001804 · Cited by 58
What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association
Allaire, M., Bruix, J., Korenjak, M., Manes, S., Maravic, Z., Reeves, H. L., Salem, R., Sangro, B., & Sherman, M. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100578 · Cited by 52
eHealth Technologies for Screening, Diagnosis, and Management of Viral Hepatitis: A Systematic Review
Haridy, J., Iyngkaran, G., Nicoll, A., Hebbard, G., Tse, E., & Fazio, T. N. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.09.011 · Cited by 44
Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017
Ellington, T. D., Momin, B., Wilson, R. J., Henley, S. J., Wu, M., & Ryerson, A. B. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0265 · Cited by 46
Innovations in Hepatitis C Screening and Treatment
Patel, A., Bui, A., Prohl, E. G., Bhattacharya, D., Wang, S., Branch, A. D., & Perumalswami, P. (2020) · Hepatology Communications · doi:10.1002/hep4.1646 · Cited by 41
Society for Maternal-Fetal Medicine Consult Series #56: Hepatitis C in pregnancy—updated guidelines
Dotters-Katz, S. K., Kuller, J. A., & Hughes, B. L. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.06.008 · Cited by 40
Treatment and prevention of viral hepatitis in pregnancy
Dionne‐Odom, J., Cozzi, G. D., Franco, R., Njei, B. M., & Tita, A. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.09.002 · Cited by 44
Estimating the Year Each State in the United States Will Achieve the World Health Organization’s Elimination Targets for Hepatitis C
Sulkowski, M., Cheng, W.-H., Marx, S. E., González, Y. S., Strezewski, J., & Reau, N. S. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01535-3 · Cited by 38
Effect of a Default Order vs an Alert in the Electronic Health Record on Hepatitis C Virus Screening Among Hospitalized Patients
Mehta, S. J., Torgersen, J., Small, D. S., Mallozzi, C. P., McGreevey, J. D., Rareshide, C. A. L., Evans, C. N., Epps, M., Stabile, D., Snider, C. K., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.2427 · Cited by 40
Hepatitis C Screening in Emergency Departments
Haukoos, J. S., Rothman, R. E., Galbraith, J. W., Hopkins, E., Hsieh, Y., Lyle, C., Gravitz, S., Kamis, K. F., White, D. A. E., Lyons, M. S., et al. (2025) · JAMA · doi:10.1001/jama.2025.10563 · Cited by 31
Removal of medicaid restrictions were associated with increased hepatitis C virus treatment rates, but disparities persist
Nephew, L. D., Wang, Y., Mohamed, K., Nichols, D., Rawl, S. M., Orman, E. S., Desai, A. P., Patidar, K. R., Ghabril, M., Chalasani, N., et al. (2022) · Journal of Viral Hepatitis · doi:10.1111/jvh.13661 · Cited by 31
Time-trends in liver cancer incidence and mortality rates in the U.S. from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database
Yao, Z., Cao, D., Yang, J., Xu, M., Meng, H., Hu, X., & Lin, N. (2023) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-23-25 · Cited by 31
Estimating the lifetime risk of a false positive screening test result
White, T., & Algeri, S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281153 · Cited by 35
The impact of immigration on hepatitis B burden in the United States: a modelling study
Razavi‐Shearer, D., Gamkrelidze, I., Pan, C. Q., Razavi‐Shearer, K., Blach, S., Estes, C., Mooneyhan, E., & Razavi, H. A. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2023.100516 · Cited by 30
Putting Evidence Into Practice: An Update on the US Preventive Services Task Force Methods for Developing Recommendations for Preventive Services
Barry, M. J., Wolff, T., Pbert, L. A., Davidson, K. W., Fan, T. M., Krist, A. H., Lin, J. S., Mabry-Hernandez, I. R., Mangione, C. M., Mills, J., et al. (2023) · The Annals of Family Medicine · doi:10.1370/afm.2946 · Cited by 30
Cost‐effectiveness of treating all hepatitis B–positive individuals in the United States
Razavi‐Shearer, D., Estes, C., Gamkrelidze, I., & Razavi, H. A. (2023) · Journal of Viral Hepatitis · doi:10.1111/jvh.13843 · Cited by 30
The prevalence of hepatitis C and hepatitis B in lesbian, gay, bisexual and transgender populations: a systematic review and meta-analysis
Moradi, G., Soheili, M., Rashti, R., Dehghanbanadaki, H., Nouri, E., Zakaryaei, F., Amini, E. E., Baiezeedi, S., Ahmadi, S., & Moradi, Y. (2022) · European journal of medical research · doi:10.1186/s40001-022-00677-0 · Cited by 33
Risk Factors for Perinatal Transmission of Hepatitis C Virus
Prasad, M. R., Saade, G. R., Clifton, R. G., Sandoval, G. J., Hughes, B. L., Reddy, U. M., Bartholomew, A. B. C., Salazar, A. E., Chien, E. K., Tita, A., et al. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005306 · Cited by 29
Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020
Feld, J. J., & Ward, J. W. (2021) · Hepatology Communications · doi:10.1002/hep4.1731 · Cited by 28
Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial
Mehta, S. J., Day, S. C., Norris, A. H., Sung, J., Reitz, C., Wollack, C., Snider, C. K., Shaw, P. A., & Asch, D. A. (2021) · BMJ · doi:10.1136/bmj.n1022 · Cited by 28
Screening for Syphilis Infection During Pregnancy
US Preventive Services Task Force, Silverstein, M., Wong, J. B., Davis, E. M., Chelmow, D. P., Coker, T. R., Fernández, A., Gibson, E., Jaén, C. R., Krousel-Wood, M. A., et al. (2025) · JAMA · doi:10.1001/jama.2025.5009 · Cited by 27
Hepatitis C Virus Testing During Pregnancy After Universal Screening Recommendations
Kaufman, H. W., Osinubi, A., Meyer, W. A., Khan, M. A., Huang, X., Panagiotakopoulos, L., Thompson, W., Nelson, N. P., & Wester, C. (2022) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004822 · Cited by 27
It Is Time for a Simplified Approach to Hepatitis B Elimination
Dieterich, D. T., Graham, C. S., Wang, S., Kwo, P. Y., Lim, Y., Liu, C., Agarwal, K., & Sulkowski, M. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2022.10.004 · Cited by 27
Responsible Inclusion of Pregnant Individuals in Eradicating HCV
Jhaveri, R. R., Yee, L. M., Antala, S., Murphy, M., Grobman, W. A., & Shah, S. K. (2021) · Hepatology · doi:10.1002/hep.31825 · Cited by 27
Data Quality in Electronic Health Record Research: An Approach for Validation and Quantitative Bias Analysis for Imperfectly Ascertained Health Outcomes Via Diagnostic Codes
Goldstein, N. D., Kahal, D., Testa, K., Gracely, E., & Burstyn, I. (2022) · Harvard Data Science Review · doi:10.1162/99608f92.cbe67e91 · Cited by 26
Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United States
Storandt, M. H., Tella, S. H., Wieczorek, M. A., Hodge, D. O., Elrod, J. K., Rosenberg, P. S., Jin, Z., & Mahipal, A. (2024) · Cancers · doi:10.3390/cancers16040684 · Cited by 25
Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program in the First 22 Months of Implementation
Mera, J., Williams, M. B., Essex, W., McGrew, K. M., Boeckman, L. M., Gahn, D., Miller, A., Durham, D. P., Fox, J. L., David, C., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.30427 · Cited by 25
Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study
Barocas, J. A., Savinkina, A. A., Lodi, S., Epstein, R. L., Bouton, T. C., Sperring, H., Hsu, H., Jacobson, K. R., Schechter‐Perkins, E. M., Linas, B. P., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab779 · Cited by 25
2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report
Li, P. K., Bavanandan, S., Mohamed, R. B., Szeto, C., Wong, V. W., Chow, K. M., Dan, Y.-Y., Huang, C., Lai, C., Tanwandee, T., et al. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.05.001 · Cited by 24
Time for universal hepatitis B screening for Australian adults
Allard, N. L., MacLachlan, J. H., Tran, L., Yussf, N., & Cowie, B. C. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51114 · Cited by 24
The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population
Ferrante, N. D., Newcomb, C. W., Forde, K. A., Leonard, C. E., Torgersen, J., Linas, B. P., Rowan, S. E., Wyles, D. L., Kostman, J. R., Trooskin, S. B., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac445 · Cited by 23
Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic
Bajis, S., Applegate, T. L., Grebely, J., Matthews, G. V., & Dore, G. J. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa366 · Cited by 23
Current and future strategies for the treatment of chronic hepatitis C
Alshuwaykh, O. S., & Kwo, P. Y. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0230 · Cited by 24
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma
Parikh, N. D., Mehta, N. J., Hoteit, M. A., Yang, J. D., John, B. V., Moon, A. M., Salgia, R. J., Pillai, A. A., Kassab, I. A., Saeed, N., et al. (2022) · Cancer · doi:10.1002/cncr.34378 · Cited by 22
DNA-directed formation of plasmonic core–satellite nanostructures for quantification of hepatitis C viral RNA
Jaitpal, S., Ng, K. W., Juan, A. M. T. S., Martinez, C., Phillips, C., Tripathy, S., & Mabbott, S. B. (2024) · Chemical Science · doi:10.1039/d4sc00891j · Cited by 21
Updated CDC Recommendations for Universal Hepatitis C Virus Screening Among Adults and Pregnant Women
Havens, P. L., & Anderson, J. (2020) · JAMA · doi:10.1001/jama.2020.3693 · Cited by 21
Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure
Spradling, P. R., Zhong, Y., Moorman, A. C., Rupp, L. B., Lü, M., Gordon, S. C., Teshale, E. H., Schmidt, M. A., Daida, Y. G., Boscarino, J. A., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1632 · Cited by 20
Hepatitis C infection seroprevalence in pregnant women worldwide: a systematic review and meta-analysis
Abbasi, F., Almukhtar, M., Naghibi, A. F., Alizadeh, F., Moghadam, K. B., Tadi, M. J., Ghadimi, S., Bagheri, K. H., Babaei, H., Bijani, M. H., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102327 · Cited by 20
Universal Screening for Hepatitis C Virus Infection
Graham, C. S., & Trooskin, S. B. (2020) · JAMA · doi:10.1001/jama.2019.22313 · Cited by 20
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion
Liang, P. S., Kwon, S. C., Cho, I., Trinh‐Shevrin, C., & Yi, S. S. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.12.001 · Cited by 20
Will prior health insurance authorization for medications continue to hinder hepatitis C treatment delivery in the United States? Perspectives from hepatitis C treatment providers in a large urban healthcare system
Javanbakht, M., Archer, R., & Klausner, J. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241615 · Cited by 20
Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts
Wang, A. E., Hsieh, E. P., Turner, B. J., & Terrault, N. A. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07628-9 · Cited by 18
Advancing Hepatitis C Elimination through Opt-Out Universal Screening and Treatment in Carceral Settings, United States
McNamara, M. S., Furukawa, N. W., & Cartwright, E. J. (2024) · Emerging infectious diseases · doi:10.3201/eid3013.230859 · Cited by 17
A Structural Competency Curriculum for Primary Care Providers to Address the Opioid Use Disorder, HIV, and Hepatitis C Syndemic
Bagchi, A. D. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00210 · Cited by 17
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion
Liang, P. S., Kwon, S. C., Cho, I., Trinh‐Shevrin, C., & Yi, S. S. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.01.008 · Cited by 17
Inverse probability weighting for selection bias in a Delaware community health center electronic medical record study of community deprivation and hepatitis C prevalence
Goldstein, N. D., Kahal, D., Testa, K., & Burstyn, I. (2021) · Annals of Epidemiology · doi:10.1016/j.annepidem.2021.04.011 · Cited by 17
Association of Individual and Community Factors With Hepatitis C Infections Among Pregnant People and Newborns
Patrick, S. W., Dupont, W. D., McNeer, E. A., McPheeters, M. L., Cooper, W. O., Aronoff, D. M., Osmundson, S. S., & Stein, B. D. (2021) · JAMA Health Forum · doi:10.1001/jamahealthforum.2021.3470 · Cited by 17
Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance
O’Brien, S. F., Reedman, C. N., Osiowy, C., Bolotin, S., Yi, Q., Lourenço, L., Lewin, A., Binka, M., Caffrey, N., & Drews, S. J. (2023) · Viruses · doi:10.3390/v15020409 · Cited by 16
Global importance of new treatment strategies to efforts to control hepatitis B virus
Forbes, C. A., Lavoie, L., Satram, S., Shen, L., Thanawala, V. J., Arizpe, A., & Terrault, N. A. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2225771 · Cited by 15
A Synopsis of Hepatitis C Virus Treatments and Future Perspectives
Medina, C., García, A. H., Crespo, F. I., Toro, F., Mayora, S. J., & Sanctis, J. B. D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100521 · Cited by 15
Outcomes of a Pharmacist-Led Hepatitis C Virus Treatment Program in an Urban Safety-Net Health System, Chicago, 2017-2019
Hunt, B. R., Cetrone, H., Sam, S., & Glick, N. R. (2021) · Public Health Reports · doi:10.1177/00333549211015664 · Cited by 15
Cascade of Hepatitis C Virus Care Among Patients With Substance Use Disorders
Jiang, X., Parker, R. L., Vouri, S. M., Lo‐Ciganic, W., Diaby, V., Henry, L. L., & Park, H. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.04.013 · Cited by 15
Optimizing hepatitis B virus screening in the United States using a simple demographics‐based model
Ramrakhiani, N. S., Chen, V. L., Le, M. H., Yeo, Y. H., Barnett, S. D., Waljee, A. K., Zhu, J., & Nguyen, M. H. (2021) · Hepatology · doi:10.1002/hep.32142 · Cited by 15
Inpatient Hepatitis C Treatment Coordination and Initiation for Patients Who Inject Drugs
McCrary, L. M., Roberts, K., Bowman, M. C., Castillo, B., Darling, J. M., Dunn, C., Jordan, R., Young, J. E., & Schranz, A. J. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08386-y · Cited by 14
Screening for Hepatitis C Virus: How Universal Is Universal?
Jhaveri, R. R. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.06.012 · Cited by 14
Kidney utilization and outcomes of liver transplant recipients who were listed for kidney after liver transplant after the implementation of safety net policy
Homkrailas, P., Ayoub, W. S., Martin, P. B., & Bunnapradist, S. (2021) · Clinical Transplantation · doi:10.1111/ctr.14522 · Cited by 14
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017–2019
Reau, N. S., Sulkowski, M., Thomas, E., Sundaram, V., Xu, Q., Cheng, W., Marx, S. E., Hayes, O., Manthena, S. R., Chirikov, V., et al. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01928-y · Cited by 14
Health Within Reach—a Patient-Centered Intervention to Increase Hepatitis B Screening Among Asian Americans: a Randomized Clinical Trial
Khalili, M., Kim, N. J., Tsoh, J. Y., Walsh, J. M. E., Goldman, L., Gildengorin, G. L., Wong, C., Tran, M. T., Yu, E., Sharp, M. T., et al. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07232-3 · Cited by 14
Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States
Chaillon, A., Wynn, A., Kushner, T., Reau, N. S., & Martin, N. K. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa362 · Cited by 14
Disparities in presentation and management of chronic hepatitis B among Hispanics in a diverse safety net system
Wang, A. E., Terrault, N. A., Fong, T., & Zhou, K. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000081 · Cited by 13
Expanding hepatitis C virus test uptake using self-testing among men who have sex with men in China: two parallel randomized controlled trials
Wang, C., Zhao, P., Weideman, A. M., Xu, W., Ong, J. J., Jamil, M. S., Yang, B., & Tucker, J. D. (2023) · BMC Medicine · doi:10.1186/s12916-023-02981-w · Cited by 13
Timing of elimination of hepatitis C virus in Canada's provinces.
Feld, J. J., Klein, M. B., Rahal, Y., Lee, S. S., Mohammed, S. R., King, A., Smyth, D. J., González, Y. S., Nugent, A., & Janjua, N. Z. (2022) · PubMed Central · doi:10.3138/canlivj-2022-0003 · Cited by 13
Resource Management through Artificial Intelligence in Screening Programs—Key for the Successful Elimination of Hepatitis C
DUDUVECHE, A. E., Mămuleanu, M., Streba, C. T., Doica, I. P., Diculescu, M. M., Gheonea, D. I., & Oancea, C. N. (2022) · Diagnostics · doi:10.3390/diagnostics12020346 · Cited by 13
State-Specific Hepatitis C Virus Clearance Cascades — United States, 2013–2022
Tsang, C. A., Tonzel, J. L., Symum, H., Kaufman, H. W., Meyer, W. A., Osinubi, A., Thompson, W., & Wester, C. (2024) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7321a4 · Cited by 12
Health Economics Research in Primary Prevention of Cancer: Assessment, Current Challenges, and Future Directions
Ekwueme, D. U., Halpern, M. T., Chesson, H. W., Ashok, M., Drope, J. M., Hong, Y., Maciosek, M. V., Pesko, M. F., & Kenkel, D. (2022) · JNCI Monographs · doi:10.1093/jncimonographs/lgac014 · Cited by 13
Trends in fatal and nonfatal overdose by race among people who inject drugs in Baltimore, Maryland from 1998 to 2019
Genberg, B. L., Gicquelais, R. E., Astemborski, J. A., Knight, J., Buresh, M. E., Sun, J., German, D., Thomas, D. L., Kirk, G. D., & Mehta, S. H. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109152 · Cited by 11
A retrospective, descriptive study of hepatitis C testing, prevalence, and care continuum among adults on probation
Kamis, K. F., Wyles, D. L., Minturn, M. S., Scott, T., McEwen, D., Hurley, H., Prendergast, S. J., Gunter, J., & Rowan, S. E. (2022) · Health & Justice · doi:10.1186/s40352-022-00191-9 · Cited by 11
Effect of relaxing hepatitis C treatment restrictions on direct-acting antiviral use in a Medicaid program: an interrupted time series analysis
Herink, M. C., Geddes, J., Vo, K., Zaman, A., & Hartung, D. M. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.7.856 · Cited by 11
Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress
Blach, S., Brown, K., Brown, R. S., Gholam, P. M., Terrault, N. A., Estes, C., & Razavi, H. A. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.11.021 · Cited by 10
Association of Medicaid expansion with health insurance, unmet need for medical care and substance use disorder treatment among people who inject drugs in 13 US states
Cooper, H. L. F., Beane, S., Yarbrough, C. R., Haardörfer, R., Ibragimov, U., Haley, D. F., Linton, S. L., Beletsky, L. A., Landes, S., Lewis, R., et al. (2023) · Addiction · doi:10.1111/add.16383 · Cited by 9
There’s just not enough time: a mixed methods pilot study of hepatitis C virus screening among baby boomers in primary care
Kasting, M. L., Rathwell, J. A., Gabhart, K. M., García, J., Roetzheim, R. G., Carrasquillo, O., Giuliano, A. R., & Vadaparampil, S. T. (2020) · BMC Family Practice · doi:10.1186/s12875-020-01327-2 · Cited by 8
Hepatitis C Virus Reflex Testing Protocol in an Emergency Department
Manteuffel, J. J., Lee, M., Bussa, R., Sabagha, N., Chaudhry, K., Ross, J., Cook, M., Rammal, J., Sridasyam, K., Klausner, H., et al. (2022) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2021.10.52468 · Cited by 8
HCV universal EHR prompt successfully increases screening, highlights potential disparities
Hack, B., Sanghavi, K. K., Gundapaneni, S., Fernandez, S. J., Hughes, J., Huang, S. S., Basch, P., Fong, A., & Fishbein, D. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279972 · Cited by 9
Advancing research, awareness, screening, and linkage to care to eliminate HDV in the U.S.
Glynn, M., Cohen, C. A., Gish, R. G., Andrews, R., Trang, A., Zovich, B., Hall, W., Clary, R. T., Balestreri, J., Scott, L., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000168 · Cited by 9
Hepatitis B Virus Elimination in the U.S.: Time to Dismantle Barriers and Implement Solutions
Wang, S., Cohen, C. A., Tang, A. S., & Graham, C. S. (2021) · Current Hepatology Reports · doi:10.1007/s11901-020-00557-3 · Cited by 9
Atherosclerotic Cardiovascular Disease in Individuals with Hepatitis C Viral Infection
Bailey, A. L., Al-Adwan, S. A., Sneij, E., Campbell, N., & Wiisanen, M. E. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01475-6 · Cited by 9
Hepatitis C Virus in Neonates and Infants
Epstein, R. L., & Espinosa, C. M. (2021) · Clinics in Perinatology · doi:10.1016/j.clp.2021.03.007 · Cited by 9
Identifying barriers and facilitators of the inclusion of pregnant individuals in hepatitis C treatment programs in the United States
Yee, L. M., Shah, S. K., Grobman, W. A., Labellarte, P. Z., Barrera, L., & Jhaveri, R. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277987 · Cited by 9
Universal Adult Hepatitis B Screening and Vaccination as the Path to Elimination
So, S. K., Terrault, N. A., & Conners, E. E. (2023) · JAMA · doi:10.1001/jama.2023.2806 · Cited by 9

Authors: US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., Kubik, M., Ogedegbe, G., Owens, D. K., Pbert, L., Silverstein, M., Simon, M. A., Tseng, C.-W., & Wong, J. B.
Affiliations: Virginia Commonwealth University (US)
Northwell Health (US)
Harvard University (US)
Oregon Health & Science University (US)
University of North Carolina at Chapel Hill (US)
Mayo Clinic (US)
George Mason University (US)
New York University (US)
University of Massachusetts Chan Medical School (US)
Boston University (US)
Northwestern University (US)
University of Hawaiʻi at Mānoa (US)
Tufts University (US)
Corresponding author: Krist, Alex H.
ORCID: Krist, Alex H.
Davidson, Karina W.
Mangione, Carol M.
Barry, Michael J.
Cabana, Michael
Caughey, Aaron B.
Donahue, Katrina
Doubeni, Chyke A.
Epling, John W.
Kubik, Martha
Ogedegbe, Gbenga
Pbert, Lori
Silverstein, Michael
Simon, Melissa A.
Tseng, Chien-Wen
Wong, John B.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2020-12-15
Volume: 324
Issue: 23
Pages: 2415
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2020.22980
OpenAlex: W3010174353
Cited by: 212
References: 49
Citations by year: 2026: 13 · 2025: 11 · 2024: 23 · 2023: 35 · 2022: 38 · 2021: 55 · 2020: 37
FWCI: 29.57
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
eScholarship@UMassChan (submittedVersion)
eScholarship (California Digital Library) (submittedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords: hepatitis B virus, hepatitis B screening, chronic hepatitis B, adolescents, adults, vulnerable populations, asymptomatic infection, hepatitis B vaccination, antiviral therapy, screening accuracy, net benefit
MeSH terms: Adolescent, Adult, Hepatitis B Surface Antigens, Hepatitis B virus, Humans, Mass Screening, Risk Factors, United States, Hepatitis B Vaccines, Hepatitis B, Chronic, Emigrants and Immigrants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks